Terapia Génica del Cáncer
TGC
Medical University of Graz
Graz, AustriaPublicaciones en colaboración con investigadores/as de Medical University of Graz (1)
2021
-
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
Journal of Clinical Oncology, Vol. 39, Núm. 20, pp. 2304-2312